§ 13F · FUND PROFILE
Pivotal bioVenture Partners Investment Advisor LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $173M (13F)Positions · 10Turnover · — · Q1Filed · May 14, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$7M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | PCVX | VAXCYTE INC | 1.37M | $80M | 28.5% | ±0% |
| 2 | OCS | OCULIS HOLDING AG | 1.68M | $45M | 16.0% | −27% |
| 3 | EVMN | EVOMMUNE INC | 1.93M | $44M | 15.8% | ±0% |
| 4 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1.36M | $32M | 11.4% | −1% |
| 5 | TRVI | TREVI THERAPEUTICS INC | 1.55M | $19M | 6.6% | +24% |
| 6 | IMNM | IMMUNOME INC | 733K | $16M | 5.7% | ±0% |
| 7 | MPLT | MAPLIGHT THERAPEUTICS INC | 611K | $12M | 4.4% | ±0% |
| 8 | ZBIO | ZENAS BIOPHARMA INC | 592K | $12M | 4.1% | ±0% |
| 9 | BIOA | BIOAGE LABS INC | 653K | $11M | 4.1% | ±0% |
| 10 | AVTX | AVALO THERAPEUTICS INC | 296K | $4M | 1.6% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE PIVOTAL SIGNAL
AC read
Pivotal bioVenture Partners Investment Advisor LLC is a Other fund managing $173 million in assets. The fund runs a focused portfolio of just 10 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed